Telepsychiatry in Brazil during the COVID-19 pandemic: Did we exchange a walk-on part in a war for a lead role in a cage?

Nascimento, Isabella

doi:10.1590/0047-2085000000294

Cited by 1 publication

(2 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Today, we already have data on its impact on primary and specialized outpatient care, and also that it was crucial in management of critical ill patients with COVID-19. [38][39][40] Other studies worldwide have also found higher rates of remote care use. A survey presented by Ziadé et al 41 regarding rheumatologic practice in Arab countries during the pandemic showed that 70% of rheumatologists use remote health assistance, especially by telephone and email.…”

Section: Discussionmentioning

confidence: 94%

See 1 more Smart Citation

How Did Patients Living With Immune-Mediated Rheumatic Diseases Face the Beginning of the COVID-19 Pandemic in Brazil? Results of the COnVIDa Study

et al. 2022

View full text Add to dashboard Cite

Background:The coronavirus disease 2019 (COVID-19) pandemic has brought additional burden to patients living with immune-mediated rheumatic diseases (IMRDs), especially at the beginning of 2020, for which information for this population is lacking.Methods: COnVIDa is a cross-sectional study on patients with IMRD from all regions of Brazil who were invited to answer a specific and customized Web questionnaire about how they were facing the COVID-19 pandemic, especially focusing on health care access, use of medications, and patient-reported outcomes related to IMRD activity. The questionnaire was applied from June 1 to 30, 2020. Results:In total, 1722 of 2576 patients who answered the Web questionnaire were included in the final analysis. Participants were most frequently women, 56% were between 31 and 50 years old, and most (55%) has private health insurance. The most commonly reported IMRD was rheumatoid arthritis (39%), followed by systemic lupus erythematosus (28%). During the study period, 30.7% did not have access to rheumatology consultations, and 17.6% stopped chronic medications. Telemedicine was reported in 44.8% of patients. Conclusion:COnVIDa demonstrated a negative impact on health care access and treatment maintenance of patients living with IMRD during the COVID-19 pandemic. However, it also presented an uptake of telemedicine strategies. Data presented in this study may assist future coping policies.

show abstract

Section: Discussionmentioning

confidence: 94%

“…Until then, as a matter of debate, 37 it was regularized by the Ministry of Health in March 2020 and then widely applied. Today, we already have data on its impact on primary and specialized outpatient care, and also that it was crucial in management of critical ill patients with COVID-19 38–40 …”

Section: Discussionmentioning

confidence: 99%